These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 206202)

  • 1. Effect of amphotericin B methyl ester on vesicular stomatitis virus morphology.
    Jordan GW; Humphreys S; Zee YC
    Antimicrob Agents Chemother; 1978 Feb; 13(2):340-1. PubMed ID: 206202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effects of amphotericin B methyl ester.
    Jordan GW; Seet EC
    Antimicrob Agents Chemother; 1978 Feb; 13(2):199-204. PubMed ID: 206201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of amphotericin B methyl ester in the prevention and therapy of herpetic keratitis.
    Shiota H; Jones BR; Schaffner CP
    Trans Ophthalmol Soc U K (1962); 1977 Jul; 97(2):318-23. PubMed ID: 205016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amphotericin B and its methyl ester on the antiviral activity of polyinosinic:polycytidylic acid.
    Borden EC; McBain JA; Leonhardt PH
    Antimicrob Agents Chemother; 1979 Aug; 16(2):203-9. PubMed ID: 225986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of filipin on the structure and biological activity of enveloped viruses.
    Majuk Z; Bittman R; Landsberger FR; Compans RW
    J Virol; 1977 Dec; 24(3):883-92. PubMed ID: 201781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants.
    Waheed AA; Ablan SD; Mankowski MK; Cummins JE; Ptak RG; Schaffner CP; Freed EO
    J Biol Chem; 2006 Sep; 281(39):28699-711. PubMed ID: 16882663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and biochemical characterization of vesicular stomatitis virus with low infectivity released from interferon treated cells.
    Maheshwari RK; Friedman RM
    Uttar Pradesh State Dent J; 1980 Jul; 11(3):95-110. PubMed ID: 6159713
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of the surface projections of different strains of vesicular stomatitis virus.
    Bussereau F; Cartwright B; Doel TR; Brown F
    J Gen Virol; 1975 Nov; 29(2):189-98. PubMed ID: 213529
    [No Abstract]   [Full Text] [Related]  

  • 9. Is cytoskeleton involved in vesicular stomatitis virus reproduction?
    Genty N; Bussereau F
    J Virol; 1980 Jun; 34(3):777-81. PubMed ID: 6247512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives.
    Oblack DL; Hewitt WL; Martin WJ
    Antimicrob Agents Chemother; 1981 Jan; 19(1):106-9. PubMed ID: 7247350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative susceptibility of Candida albicans to amphotericin B and amphotericin B methyl ester.
    Bannatyne RM; Cheung R
    Antimicrob Agents Chemother; 1977 Oct; 12(4):449-50. PubMed ID: 335958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of the envelope of vesicular stomatitis virus.
    Taube SE; Rothfield LI
    J Virol; 1978 Jun; 26(3):730-5. PubMed ID: 209217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of amphotericin inhibit infection with human immunodeficiency virus in vitro by different modes of action.
    Hansen JE; Witzke NM; Nielsen C; Mathiesen LR; Teglbjaerg LS; Nielsen CM; Nielsen JO
    Antiviral Res; 1990 Sep; 14(3):149-59. PubMed ID: 2080870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant-mediated increases in the antifungal activities of amphotericin B and its methyl ester derivative.
    Beggs WH; Andrews FA
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):389-92. PubMed ID: 6997948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A slow sedimenting infective component in vesicular stomatitis virus.
    Warrington RE
    Arch Gesamte Virusforsch; 1969; 28(3):429-33. PubMed ID: 4318621
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of phospholipase C and cholesterol oxidase on membrane integrity, microviscosity, and infectivity of vesicular stomatitis virus.
    Moore NF; Patzer EJ; Barenholz Y; Wagner RR
    Biochemistry; 1977 Oct; 16(21):4708-15. PubMed ID: 199240
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural study of vesicular stomatitis virus G protein in the virion envelope.
    Taube SE; Braun PC
    J Gen Virol; 1982 Apr; 59(Pt 2):319-27. PubMed ID: 6281372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sialic acid in infection with vesicular stomatitis virus.
    Cartwright B; Brown F
    J Gen Virol; 1977 Apr; 35(1):197-9. PubMed ID: 192844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the virion-associated RNA polymerase of vesicular stomatitis virus by melittin.
    Roy J; Chanda PK; Thornton GB; Luk D; Banerjee AK
    Biochem Biophys Res Commun; 1982 Apr; 105(4):1265-71. PubMed ID: 6285902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.